ABVX:EPA
Abivax SA
၈၂.၄၅ €
arrow_downward
-၁.၂၆%(-၁.၀၅) 1D
အောက် ၅, GMT+၂ ၁၅:၁၀:၅၄ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABVX...
Open
၈၃.၄၀ €
High
၈၃.၄၀ €
Low
၈၂.၄၅ €
Mkt. cap
၇၂၁.၆၉ ဋေ
Avg. vol.
၁.၅၆ သိန်း
Volume
၂.၅၉ သောင်း
52-wk high
၁၃၉.၀၀ €
52-wk low
၆၀.၄၅ €
EPS
-၅.၂၀ €
Shares outstanding
၈.၇၅ ကုဋေ
No. of employees
၉၈
Open
၈၃.၄၀ €
High
၈၃.၄၀ €
Low
၈၂.၄၅ €
Mkt. cap
၇၂၁.၆၉ ဋေ
Avg. vol.
၁.၅၆ သိန်း
Volume
၂.၅၉ သောင်း
52-wk high
၁၃၉.၀၀ €
52-wk low
၆၀.၄၅ €
EPS
-၅.၂၀ €
Shares outstanding
၈.၇၅ ကုဋေ
No. of employees
၉၈
News stories
From web sources and news partners
Voice of Alexandria
·
ပြီးခဲ့သည့် ၄၆ မိနစ်
U.S. Based Rare Earth Company Winner Water to Join SPD and Mobix Labs (Nasdaq: MOBX) National Security Matters Initiative
PR Newswire
·
ပြီးခဲ့သည့် ၂၄ မိနစ်
Estée Lauder at NYSE for Breast Cancer Awareness Month: NYSE Content Update
Business Wire
·
ပြီးခဲ့သည့် ၁ နာရီ
Powerus (Nasdaq: PUSA) Awarded $82 Million Order for Counter-Unmanned Aerial Systems
MarketWatch
·
ပြီးခဲ့သည့် ၂ နာရီ
An AI ‘reality check’ may take the S&P 500 to 5,000. Here are the trades to make, this strategist says.
Profile
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated.
The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France. Wikipedia
About Abivax SA
CEOMarc de Garidel | Hartmut J. Ehrlich
Employees၉၈
Founded၂၀၁၃ ဒီ ၄
Headquarters-
Sector-
Websiteabivax.com